ID: ALA3341904

Max Phase: Preclinical

Molecular Formula: C13H8Cl2INO2

Molecular Weight: 408.02

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1cc(Cl)cc(Cl)c1)c1cc(I)ccc1O

Standard InChI:  InChI=1S/C13H8Cl2INO2/c14-7-3-8(15)5-10(4-7)17-13(19)11-6-9(16)1-2-12(11)18/h1-6,18H,(H,17,19)

Standard InChI Key:  OLACLIUUVMOFGQ-UHFFFAOYSA-N

Associated Targets(Human)

Proto-oncogene c-JUN 434 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 408.02Molecular Weight (Monoisotopic): 406.8977AlogP: 4.56#Rotatable Bonds: 2
Polar Surface Area: 49.33Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.50CX Basic pKa: CX LogP: 4.90CX LogD: 4.65
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.72Np Likeness Score: -1.66

References

1. Ye N, Ding Y, Wild C, Shen Q, Zhou J..  (2014)  Small molecule inhibitors targeting activator protein 1 (AP-1).,  57  (16): [PMID:24831826] [10.1021/jm5004733]

Source